Advance Search
ZHENG Huifen, ZONG Huihua, YU Yan, ZHAO Yanping. Clinical effect of edaravone on treatment of patients with acute cerebral infarction and its influence on serum SOD and MDA[J]. Journal of Clinical Medicine in Practice, 2014, (17): 18-21. DOI: 10.7619/jcmp.201417006
Citation: ZHENG Huifen, ZONG Huihua, YU Yan, ZHAO Yanping. Clinical effect of edaravone on treatment of patients with acute cerebral infarction and its influence on serum SOD and MDA[J]. Journal of Clinical Medicine in Practice, 2014, (17): 18-21. DOI: 10.7619/jcmp.201417006
shu

Clinical effect of edaravone on treatment of patients with acute cerebral infarction and its influence on serum SOD and MDA

More Information
  • Published Date: October 16, 2014
    Graphical Abstract
    • Abstract
  • Obj ective To observe the clinical effect of edaravone on treatment of patients with acute cerebral infarction (ACI)and its influence on serum superoxide dismutase (SOD)and malondialdehyde (MDA).Methods A total of 64 ACI patients were randomly divided into control group (31 cases)treated with basic medicines and treatment group (33 cases)added with with edar-avone.Clinical efficacy,neurological function deficit improvement rate,American National Insti-tutes of Health Stroke Scale (NIHSS)and Barthel index (BI)as well as serum SOD and MDA level changes in both groups were observed.Results 14 d after treatment,the clinical efficacy in treat-ment group was 84.85%,significantly higher than the 61.29% in control group (P<0.01). NIHSS and Barthel scores were better after treatment than those before (P<0.01),and differences between two groups were also significant (P<0 .05 ).After treatment,SOD level was higher in treatment group (P<0 .0 1 )and lower in control group than those before treatment (P<0 .0 1 ), whereas MDA level was lower in treatment group (P<0 .0 1 )and higher in control group than those before treatment (P<0 .05 ).Additionally,there had no severe adverse responses in both groups. Conclusion On the basis of basic treatment,the application of edaravone has favorable clinical effi-cacy and safety in the treatment of ACI .
    • FullText(HTML)
    • References (15)
  • 张千, 汪莉. 自由基清除剂依达拉奉在缺血性脑卒中的临床应用 [J]. 内科, 2009(4):617.doi: 10.3969/j.issn.1673-7768.2009.04.065.
    彭晓琴, 张兆辉, 何国厚. 依达拉奉联合银杏达莫治疗急性脑梗死的Meta分析 [J]. 卒中与神经疾病, 2012(3):159.doi: 10.3969/j.issn.1007-0478.2012.03.009.
    Nakase T, Yoshioka S, Suzuki A. Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in hu-man brain ischemic stroke [J]. BMC neurology, 20 1(1):39.
    陈敏, 陈艳红, 潘庆敏. 急诊期行高压氧治疗对脑梗死患者的临床疗效观察 [J]. 神经损伤与功能重建, 2012(3):198.doi: 10.3870/sjsscj.2012.03.012.
    祝春华, 张祥建. 脑出血后病理生理机制及临床治疗对策 [J]. 中国神经免疫学和神经病学杂志, 2012(3):47.doi: 10.3969/j.issn.1006-2963.2012.03.005.
    杨政, 吴玉林. 治疗急性脑梗死的新型脑保护药依达拉奉 [J]. 中国新药杂志, 2002, (12):911.doi: 10.3321/j.issn:1003-3734.2002.12.004.
    Kimura K, Aoki J, Sakamoto Y. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients-A preliminary study [J]. Journal of the Neurological Sciences, 2012(1):132.
    Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction.Randomized, placebo-control ed, double-blind study at multicenters [J]. Cerebrovascular Diseases, 2003(3):222.
    印卫兵, 王蔚, 丁新生. 在中国应用依达拉奉治疗急性脑梗死临床疗效的Meta分析 [J]. 中国脑血管病杂志, 2009, (10):532.doi: 10.3969/j.issn.1672-6921.2009.10.008.
    韩秋果. 依达拉奉治疗急性脑梗死临床疗效及对SOD, MDA, CAT的影响 [D]. 长春:吉林大学, 2009.
    Aoki M, Warita H, Mizuno H. Feasibility study for functional test battery of SOD transgenic rat (H46R)and e-valuation of edaravone, a free radical scavenger [J]. Brain re-search, 2011.321.
    Hori K, Tsuji M, Iino T. Protective effect of edar-avone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb [J]. BMC muscu-loskeletal disorders, 2013(1):113.
    魏林节, 冯国君, 童红让. 丹参注射液与依达拉奉联合治疗急性脑梗死的临床疗效观察 [J]. 临床神经病学杂志, 2014, (27):58.
    刘家斌, 李广生, 邓江华. 依达拉奉对急性反射性损伤兔组织核转录因子-kB表达和丙二醛含量的影响 [J]. 临床神经病学杂志, 2013, (26):358.
    张晓庆. 依达拉奉药理作用和临床应用的研究进展 [J]. 医药导报, 2011(7):918.doi: 10.3870/yydb.2011.07.029.
    • Related Articles

  • Related Articles

    [1]LI Hongli, YAN Huili. Relationships of glucose metabolism with sex hormones and endometrial receptivity in patients with polycystic ovary syndrome at childbearing age[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 106-111. DOI: 10.7619/jcmp.20233856
    [2]ZHOU Lina, HAN Yanhua, GENG Tiantian, LIU Li. Research progress in effects of hyperandrogenin and insulin resistance on placental pathology of polycystic ovary syndrome
    [J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 137-141. DOI: 10.7619/jcmp.20223478
    [3]DONG Yaguang, ZHU Lin, CHEN Haoyang. Research progress of complications of polycystic ovary syndrome in obstetric department and mechanisms[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 112-116. DOI: 10.7619/jcmp.20214639
    [4]CHEN Haixia, LI Jian, WU Fengyun, BAI Yueran, GU Bei, SONG Xiaohong, SUN Yu, CUI Guangxia, WANG Zijun, WANG Xiaoxue, YIN Cong, YANG Mukun, FAN Li, BAI Wenpei, JIANG Bo. Clinical pathway of ketogenic diet in the treatment of patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 5-7,32. DOI: 10.7619/jcmp.20210722
    [5]JIA Xiaolin, LI Na. Clinical efficiency of laparoscopic ovarian perforation combined with clomiphene citrate and human chorionic gonadotropin in treating infertility induced by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 102-105. DOI: 10.7619/jcmp.201907027
    [6]BAI Liran, LI Jian, NIU Litian, WANG Aili, WU Fengyun, BAI Wenpei, JIANG Bo. Preliminary report of a single-center clinical study for ketogenic diet intervention of polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 2-5. DOI: 10.7619/jcmp.201907002
    [7]BAO Xudong, XU Yang, FU Rong. Effect of ethinylestradiol and cyproterone acetate tablets combined with metformin on hormone levels of patients with sterility caused by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2018, (1): 104-106,110. DOI: 10.7619/jcmp.201801032
    [8]MAYILA · Maimaiti, ZULIPIYA · Yiming. Clinical effect of clomiphene combined with human chorionic gonadotropin on ovulation induction in infertility patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2017, (17). DOI: 10.7619/jcmp.201717021
    [9]YIN Jiayao, YANG Ying. Study on modified ultra-long protocol in improving endometrial receptivity in infertile patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2016, (23): 75-77,81. DOI: 10.7619/jcmp.201623022
    [10]CAI Xiuli, YAO Jinyan, ZHANG Yijiao. Effect of Diane-35 combined with clomiphene on treatment of infertility caused by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2016, (15): 60-62. DOI: 10.7619/jcmp.201615017

  • Cited by

    Periodical cited type(14)

    1. 季晓丽，卢莹莹，赵小瑞. 酶联免疫法和金标法对HIV抗体的检测结果比较. 临床医学工程. 2024(03): 337-338 .
    2. 吴瑕. 化学发光免疫分析法与酶联免疫法检测艾滋病抗体的效果研究. 黑龙江中医药. 2023(02): 362-364 .
    3. 张婷婷. 溶血标本对化学发光免疫分析法检测HIV抗体检验结果的影响. 中国现代医生. 2022(08): 107-110 .
    4. 张缤月. 酶联免疫吸附法和实时荧光定量PCR法检验EB病毒的效果比较. 中国实验诊断学. 2022(07): 1078-1081 .
    5. 马伟刚. 溶血标本在应用化学发光免疫分析法检测HIV抗体时对检测结果的影响. 临床研究. 2022(09): 125-128 .
    6. 万琴. 不同免疫检验法抗HIV检测结果对比. 基层医学论坛. 2022(26): 55-57 .
    7. 江洋. 临床检验中化学发光免疫分析的应用效果分析. 中国实用医药. 2022(21): 87-89 .
    8. 王旭. 分析电化学发光免疫法与酶联免疫吸附试验法检测人类免疫缺陷病毒的临床效果. 中国实用医药. 2021(04): 46-48 .
    9. 刘凤. 艾滋病病毒感染实验检测方法研究进展. 应用预防医学. 2021(02): 185-188+193 .
    10. 张晨磊. 化学发光免疫分析法的研究进展. 医疗装备. 2021(14): 191-192 .
    11. 蔡贤惠. 电化学发光免疫分析与酶联免疫吸附试验检测甲型肝炎病毒Ig M抗体的对比评价. 中国医药指南. 2021(23): 74-75 .
    12. 武红斌. 不同酶免检测试剂检测抗HIV的结果比较. 临床医学研究与实践. 2020(24): 113-115 .
    13. 赵鸿翔. 人类免疫缺陷病毒抗体采用酶联免疫吸附法及电化学发光免疫分析法检测的效果. 中国医疗器械信息. 2020(24): 85-86 .
    14. 严建明，何宝贤，刘玉华. 酶联免疫法筛查HIV抗体应用于诊断艾滋病价值观察. 实用妇科内分泌电子杂志. 2020(18): 156+158 .

    Other cited types(2)

Catalog

    Get Citation
    XML
    Article views (253) PDF downloads (0) Cited by(16)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return